Abstract
Investigate the potential application of corosolic acid (CA) in the treatment of diseases causing retinal neovascularization. CA cytotoxicity effect was evaluated in ARPE-19 cells by sulforhodamine B colorimetric method, and antiangiogenic activity was studied using chorioallantoic membrane (CAM) assay. An amount of 0.01mL of CA formulations at 5, 10 and 25µM was injected in the right eyes of Wistar rats, and the contralateral eyes received the vehicle to verify the safety of ophthalmic use. Electroretinography (ERG) was performed before, 7 and 15days after CA administration. Animals were killed on the 15th day, and the histological analysis of retina was carried out under light microscopy. CA did not present cytotoxicity at concentrations below 35.5μM after 48h of treatment. The antiangiogenic activity was confirmed by CAM assay, since CA (range from 5 to 25µM) induced a significant reduction in vascularity without any signs of toxicity. ERG recordings and histological evaluation did not show any signs of retinal toxicity. CA was effective in reducing vascularity in a CAM model and was found to be safe for potential ophthalmic use.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
